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Summary
Aim: To determine whether an association exists between 
plasma lipoprotein constituents and the prevalence of 
corneal arcus in dyslipidaemic patients.
Methods: Adult patients (n = 115) were included if their 
fasting total serum cholesterol concentrations exceeded 
the 95th percentile or their serum low-density lipoprotein 
(LDL) : high density lipoprotein (HDL) ratios exceeded 
5. Slit-lamp assessment of the corneas was performed. 
Results: The study group divided into a subgroup with 
arcus 37% (43) and a subgroup without arcus 63% (72). 
Total serum cholesterol and triglyceride levels were not 
associated with corneal arcus. A significant difference 
was found (p < 0.05) between the mean levels of LDL 
cholesterol (LDL-C) in the group without arcus (5.61 
± 1.74 mmol/l) and the group with arcus (5.96 ±1.71 
mmol/l). The mean serum HDL-cholesterol (HDL-C) in 
the group with corneal arcus was 1.04 ± 0.30 mmol/l as 
opposed to 1.31 ± 0.38 mmol/l in the group without arcus 
(p < 0.005 for difference). The mean LDL-C : HDL-C 
ratio in the group without arcus was 4.28 (SD: 1.99), 
and 5.73 (SD: 2.09) in the group with a corneal arcus 
(p < 0.05). 
Conclusions: Low HDL-C levels, high LDL-C levels 
and LDL-C : HDL-C ratios > 5 have been implicated 
as risk factors of numerous circulatory diseases. The 
observations in this study suggest that the presence of 
corneal arcus in the dyslipidaemic patient correlates 
strongly with these same risk indicators. 
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A corneal arcus is a harmless, gray-white circular deposition 
of cholesterol, triglycerides, phospholipids and a small 
amount of apolipoprotein B at the periphery of the cornea.1,2 
Although harmless with regard to vision, the appearance of 
an arcus at a young age may indicate dyslipidaemia.3,4 The 
composition of a corneal arcus shows a strong resemblance 
to the composition of an arterial atherosclerotic lesion. 
There fore, it has been suggested that the occurrence of an 
arcus is associated with the presence of atherosclerosis,5,6 
and may be prognostic for premature coronary heart disease 
(CHD).7,8 Additionally, the existence of a corneal arcus 
before the age of 60 is related to an enhanced thickness 
of the intima–media in the carotid arteries of males with 
hypercholesterolaemia.9 It has been proposed that a promi-
nent arcus should be an indication for lipid screening, and 
in many cases may indicate the presence of familial hyper-
cholesterolaemia.10-12 However, it is as yet unclear exactly 
which component or components of the lipogram correlate 
with the arcus phenomenon in dyslipidaemic patients. 
The aim of this study was therefore to determine whether 
any associations exist between the different plasma lipopro-
tein constituents and the prevalence of arcus cornealis in 
dyslipidaemic subjects. 
Methods
Patient study group
The clinical history, height, weight, blood pressure and 
serum lipid profile were recorded in a group of 115 patients 
with proven dyslipidaemia presenting to the Lipid Clinic 
at the Tygerberg Academic Hospital, Cape Town, South 
Africa. Consent was obtained from the institutional Ethics 
Committee before the study commenced.
A slit-lamp examination was also performed on each 
patient by an ophthalmologist. In order to obtain a study 
group with maximum homogeneity, only patients meeting 
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the following criteria were enrolled: adults of both genders, 
18–60 years of age with a serum total cholesterol (TC) level 
> 5.2 mmol/l (i.e. > 95th percentile of the population) 
and a low-density lipoprotein cholesterol (LDL-C) : high-
density lipoprotein cholesterol (HDL-C) ratio > 5. Excluded 
were pregnant or lactating females, or subjects with severe 
hypertension (diastolic blood pressure > 115 mm Hg), his-
tory of an acute coronary event within the last six months, 
diabetes mellitus (defined as fasting blood glucose > 7.8 
mmol/l), hypothyroidism (thyroid stimulating hormone > 7.5
mU/l), any malignant tumour, significant renal impairment 
(serum creatinine > 170 µmol/l), history of pancreatitis, 
gallbladder disease including cholelithiasis, gastro-intestinal 
disease or patients who were known to be HIV positive.
All patients were treatment naïve and had not been 
on treatment with lipid-lowering medication prior to the 
lipograms. Fasting blood samples were obtained from each 
individual on three occasions over a period of four weeks. 
Subjects were only included in the study if their lipid 
parameters adhered to the inclusion criteria on each of the 
three visits.
Analytical methods
Triglyceride, TC and HDL-C levels were determined using 
a Hitachi 911 automatic analyzer (Boehringer Mannheim 
BV, Almere). LDL cholesterol was calculated using the 
Friedewald formula.
Statistical methods
Descriptive statistics including the mean, median and range 
were given for each independent and dependent variable. 
Student’s t-test was used to assess the differences between 
the continuous variables; chi-square tests to asses the differ-
ence between the categorical variables in the two groups, 
i.e. those with corneal arcus and those without corneal 
arcus.
Results
The study group consisted of 115 subjects, 82% Caucasian 
(94/115) and 18% (21/115) of mixed-race descent. The 
mean age was 49.1 years (SD = 10.2) with 64% (74) male 
and 36% (41) female. The mean values of five components 
of the serum lipogram, for the group as a whole, are depicted 
in Fig. 1. The mean TC, triglyceride and LDL-C levels 
exceeded the 95th percentile, whereas the mean serum 
HDL-C was lower than the 95th percentile of the population, 
confirming the dyslipidaemic profile of the group. 
The study group was divided into two cohorts, i.e. a 
subgroup with corneal arcus 37% (43) and a subgroup 
without arcus 63% (72) (Fig. 2). Comparison of the two 
subgroups (Table I) showed no differences in the mean age, 
gender distribution, body mass index (BMI), and systolic 
and diastolic blood pressures between the two subgroups. 
A positive family history of hypercholesterolaemia and 
cardiovascular disease was significantly more prevalent in 
the subgroup with arcus. 
Analysis of the serum lipograms of the two groups 
revealed no differences in the serum TC or serum triglyc-
eride levels. The LDL-C and HDL-C levels of the two 
subgroups differed however. The mean HDL-C level of the 
Fig. 1. Serum lipid parameters of the study group 
(n = 115) compared to the upper 95th percentile 
(mmol/l) demonstrating the dyslipidaemic nature 
of the group as a whole.
Fig. 2. The prevalence of corneal opacities divided 
the study group into two cohorts, i.e. those with no 
arcus (63%) and those with corneal arcus (37%).
TABLE I. COMPARISON OF DEMOGRAPHICS, CARDIOVASCULAR 
RISK FACTORS AND SERUM LIPID PARAMETERS BETWEEN
THE SUBGROUP WITH NORMAL CORNEAS (63%) AND THE
SUBGROUP WITH ARCUS (37%)
Variable No Arcus (n = 72) Arcus (n = 43) Significance
Demographics 
Age (years) 48.5 ± 10.9 50.1 ± 14.8
Gender (% females) 22 24
Clinical parameters 
BMI (kg/m2) 26.39 26.14
Diastolic BP (mm Hg) 85 ± 13 83 ± 11
Systolic BP (mm Hg) 124 ± 22 121 ± 17
Family history 
Hypercholesterolaemia (%) 51 64 p < 0.05
Cardiovascular disease (%) 48 56 p < 0.05
Clinical history 
Never smoked (%) 10 9
Myocardial infarction (%) 18 22
Angina pectoris (%) 23 26
Serum lipid levels 
Total cholesterol (mmol/l) 7.36 ± 1.72 7.39 ± 2.10 p < 0.05
LDL cholesterol (mmol/l) 5.61 ± 1.74 5.96 ± 1.71 p < 0.005
HDL cholesterol (mmol/l) 1.31 ± 0.38 1.04 ± 0.30 
Triglycerides (mmol/l) 2.24 ± 1.53 2.37 ± 1.28 p < 0.05 
LDL-C:HDL-C ratio 4.28 (SD: 1.99) 5.73 (SD: 2.09) 
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subgroup without arcus was 1.31 ± 0.38 mmol/l, whereas 
the mean HDL-C level of the subgroup with corneal arcus 
was 1.04 ± 0.30 mmol/l. This difference of 0.27 mmol/l was 
highly significant (p < 0.005). The mean LDL-C level in 
the subgroup without arcus was 5.61 ± 1.74 mmol/l, and in 
the subgroup with arcus 5.96 ± 1.71 mmol/l. This difference 
of 0.35 mmol/l was significant (p < 0.05). Furthermore, the 
mean LDL-C : HDL-C ratio in the subgroup without arcus 
was 4.28 (SD: 1.99) and in the subgroup with arcus, it was 
5.73 (SD: 2.09). This difference of 1.45 was also significant 
(p < 0.05). 
Discussion
The study group was meticulously selected in an effort 
to ensure a clinically homogeneous group of patients. It 
is important to note that patients were included only if 
abnormal lipid levels were their only risk factor for coronary 
artery disease. It is generally accepted that premature 
corneal arcus under the age of 50 years is an indicator 
of dyslipidaemia and not a risk factor for CHD. Previous 
studies have found correlations between arcus and age, 
and arcus and cholesterol levels, particularly the LDL-C 
concentration. Corneal arcus has not been described to be 
associated with diabetes, hypertension, obesity, triglycerides 
and HDL-C levels, but it does have a higher prevalence 
in males.
Low plasma levels of HCL-C are a strong independent 
predictor of CHD.13,14 Evidence suggests that HDL-C has a 
direct beneficial effect on the arterial wall. Metabolically, 
HDL particles with their apoprotein A play a role in the 
removal of cholesterol from peripheral cells, including those 
in atherosclerotic plaques.15 Apolipoprotein A-I (apoA-I), 
the major apoprotein in HDL, plays a role in the removal 
of cholesterol from macrophages, leading to the reduction 
of the cholesterol content of these cells in atherosclerosis. 
At least two specific receptors participate in mediating this 
protective effect. Intravenous infusion of HDL in rabbits 
has been shown to prevent atherosclerosis,16 and the over-
expression of the human apoA-I gene in mice stimulates the 
regression of pre-existing atherosclerosis.17 HDL delivers 
cholesterol to the liver in a process referred to as ‘reverse 
cholesterol transport’.18 HDL also has other functions that 
may contribute to its ability to protect against CHD, includ-
ing anti-inflammatory and antioxidant properties.19 The 
composition of a corneal arcus shows a strong resemblance 
with the composition of an arterial atherosclerotic lesion. 
Therefore, it has been suggested that the occurrence of an 
arcus is associated with the presence of atherosclerosis.
Previous studies have shown that gender plays a signifi-
cant role in the development of arcus. Females are less 
likely to develop arcus than men. This is also true for CHD 
and reduced HDL-C plasma levels. It has been reported 
that the occurrence of arcus in premenoposal women is 
rare.20 The higher HDL-C levels in women are related to 
the endogenous oestrogen. These levels decline with age, 
as do HDL-C levels. Both subgroups contained comparable 
numbers of females and it is therefore unlikely that gender 
could have skewed the results.
Compared with Caucasians, blacks of both genders have 
been shown to have higher mean levels of HDL-C.21 This 
would mean that any study that enrolls a large proportion 
of black patients would be skewed towards a higher mean 
level of HDL-C, and accordingly it would be difficult 
to demonstrate a relationship between HDL-C and the 
development of arcus in a group with a very diverse 
ethnic background. Our study group was predominantly of 
Caucasian stock with only 18% of mixed-race origin and 
no black persons. Hence it is unlikely that the results were 
skewed toward higher HDL-C levels due to race alone. 
Hoogerbrugge et al.22 has also suggested a relationship 
between HDL-C and arcus in a study group made up of only 
200 Caucasians, but with no other race groups included.
The incidence of arcus tends to increase with age in 
all race and gender groups. In fact Friedlander was of the 
opinion that the occurrence of corneal arcus approached 
100% in people over 80 years of age.23 Furthermore, it is 
accepted that mean HDL-C levels generally decline with 
age. The mean age of the subjects in our study group was 
49 years, hence age is unlikely to be a contributory factor 
to the high prevalence of arcus in this study group. In 
addition, no age difference was demonstrated between the 
two subgroups in our study. 
Conclusions
It is widely postulated that the corneal lesions found in 
corneal arcus strongly resemble the vessel wall changes 
found in atherosclerotic lesions. HDL-C protects the vessel 
wall against these changes. We suggest that the same protec-
tive effect is afforded by HDL-C in the corneal peripheral 
stroma in young dyslipidaemic patients. Conversely, the 
presence of corneal arcus in dyslipidaemic patients below 
50 years of age is suggestive of low HDL cholesterol 
levels. 
Low levels of HDL-C, high levels of LDL-C, and LDL-
C : HDL-C ratios > 5 have often been implicated as risk 
factors in the development of numerous circulatory diseases. 
The observations in this study suggest that the presence of 
corneal arcus in the dyslipidaemic patient correlate strongly 
with these same risk indicators.
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Comment
 
This clinically relevant study shows that in patients with a serum cholesterol level over 5.2 mmol, arcus 
cornealis associates with a more atherogenic lipid profile. The patients were predominantly white, middle-
aged males, of whom 37% had arcus cornealis. An arcus was more common in patients with a family history 
of hypercholesterolaemia and of cardiovascular disease. An arcus was associated with a higher LDL-C, 
lower HDL-C and, in consequence, a higher LDL-C:HDL-C ratio. It would be of interest to know if similar 
relationships exist across a broader patient group (including more women, the elderly, and races other 
than whites), and also the relationship between arcus and a direct measurement of atherosclerosis, such 
as carotid intima–media thickness.
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